Patents by Inventor Ayatoshi ANDO

Ayatoshi ANDO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT FOR FATTY LIVER DISEASE
    Publication number: 20230201163
    Abstract: An object of the present invention is to provide a therapeutic agent for fatty liver diseases. The above object can be achieved by a therapeutic agent for a fatty liver disease, comprising a compound represented by the following formula (1): or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 17, 2023
    Publication date: June 29, 2023
    Applicant: EA PHARMA CO., LTD.
    Inventors: Ayatoshi ANDO, Ippei KAWANISHI, Seiji SHIRAISHI, Harumi TANAKA, Yuki SAITOU
  • Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity
    Patent number: 10562898
    Abstract: Provided is a compound having ?4 integrin inhibitory action. The compound is a sulfonamide derivative represented by the following formula (I), or pharmaceutically acceptable salt thereof: where R1 to R5, e to h, D, and B represent those as described in the specification.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: February 18, 2020
    Assignee: EA PHARMA CO., LTD.
    Inventors: Munetaka Tokumasu, Masatsugu Noguchi, Mizuki Kawahira, Kana Iwasaki, Nobuhiko Hayakawa, Wataru Miyanaga, Yuki Saitou, Yui Yamaura, Ayatoshi Ando, Atsushi Tsuruta, Misato Noguchi
  • SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
    Publication number: 20190040059
    Abstract: Provided is a compound having ?4 integrin inhibitory action. The compound is a sulfonamide derivative represented by the following formula (I), or pharmaceutically acceptable salt thereof: where R1 to R5, e to h, D, and B represent those as described in the specification.
    Type: Application
    Filed: February 6, 2017
    Publication date: February 7, 2019
    Applicant: EA PHARMA CO., LTD.
    Inventors: Munetaka TOKUMASU, Masatsugu NOGUCHI, Mizuki KAWAHIRA, Kana IWASAKI, Nobuhiko HAYAKAWA, Wataru MIYANAGA, Yuki SAITOU, Yui YAMAURA, Ayatoshi ANDO, Atsushi TSURUTA, Misto NOGUCHI
  • Sulfonamide derivative and medicinal use thereof
    Patent number: 9533985
    Abstract: Sulfonamide compounds of a specific chemical structure in which a sulfonamide group having, as a substituent, a phenyl group or a heterocyclic group having a hetero atom(s) as a constituent element(s) is present at its terminal, and pharmaceutically acceptable salts thereof. These compounds are novel compounds having excellent ?4 integrin-inhibitory action.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: January 3, 2017
    Assignee: EA Pharma Co., Ltd.
    Inventors: Hirokazu Ueno, Takashi Yamamoto, Ryuta Takashita, Ryohei Yokoyama, Toshihiko Sugiura, Shunsuke Kageyama, Ayatoshi Ando, Hiroyuki Eda, Agung Eviryanti, Tomoko Miyazawa, Aya Kirihara, Itsuya Tanabe, Tarou Nakamura, Misato Noguchi, Manami Shuto, Masayuki Sugiki, Mizuki Dohi
  • SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF
    Publication number: 20150051395
    Abstract: Provided are sulfonamide derivatives of a specific chemical structure in which a sulfonamide group having, as a substituent, a phenyl group or a heterocyclic group having a hetero atom(s) as a constituent element(s) is present at its terminal, and pharmaceutically acceptable salts thereof. These compounds are novel compounds having excellent ?4 integrin-inhibitory action.
    Type: Application
    Filed: April 24, 2013
    Publication date: February 19, 2015
    Applicant: AJINOMOTO CO., LTD.
    Inventors: Hirokazu Ueno, Takashi Yamamoto, Ryuta Takashita, Ryohei Yokoyama, Toshihiko Sugiura, Shunsuke Kageyama, Ayatoshi Ando, Hiroyuki Eda, Agung Eviryanti, Tomoko Miyazawa, Aya Kirihara, Itsuya Tanabe, Tarou Nakamura, Misato Noguchi, Manami Shuto, Masayuki Sugiki, Mizuki Dohi
  • IMIDAZOPYRIDAZINE COMPOUNDS
    Publication number: 20120323002
    Abstract: By searching various compounds having an inhibiting activity against IL-12/IL-23 production, the present invention provides a pharmaceutical composition or a therapeutic or preventive agent for diseases related to IL-12/IL-23 excessive production each of which comprises the compound(s) of the present invention. More specifically, the present invention provides an imidazopyridazine compound having an inhibiting activity against IL-12/IL-23 production or pharmaceutically acceptable salts thereof; and a useful pharmaceutical composition or a useful therapeutic or preventive agent for diseases related to IL-12/IL-23 excessive production each of which comprises said compound or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 25, 2012
    Publication date: December 20, 2012
    Applicant: AJINOMOTO CO., INC.
    Inventors: Takashi YAMAMOTO, Ayatoshi ANDO, Nobuhiko HAYAKAWA, Masatsugu NOGUCHI, Hikaru NISHIO, Agung EVIRYANTI, Ryohei YOKOYAMA, Shunsuke KAGEYAMA, Kanna KURIBAYASHI